Molecular mechanisms of alpha1-antitrypsin null alleles

Respiratory Medicine

Volumn 94, Issue SUPPL. C, 2000, Pages

  Lee, J H ^a   Brantly, M ^b  

^a Korea University College of Medicine   (South Korea)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Null alleles; 1 antitrypsin

Indexed keywords

ALPHA 1 ANTITRYPSIN; PLASMA PROTEIN; SERINE PROTEINASE INHIBITOR;

ALLELE; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; ENZYME ACTIVITY; ENZYME INHIBITION; EXON; GENE DELETION; GENE EXPRESSION; GENETIC CODE; HOMEOSTASIS; HUMAN; INHERITANCE; LIVER DISEASE; LUNG EMPHYSEMA; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN PROCESSING; PROTEIN STRUCTURE; PROTEIN TRANSPORT; RISK ASSESSMENT; STOP CODON; EMPHYSEMA; GENETICS; REVIEW;

ALLELES; ALPHA 1-ANTITRYPSIN DEFICIENCY; CODON, TERMINATOR; EMPHYSEMA; EXONS; GENE DELETION; HUMANS; LIVER DISEASES;

EID: 0033859938     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1053/rmed.2000.0851     Document Type: Article

References (28)

1. Alpha 1-antitrypsin deficiency: Pathogenesis and treatment
2. al-antitrypsin deficiency
3. Clinical features and molecular characteristics of alpha 1-antitrypsin deficiency
4. The alpha 1-antitrypsin gene and its deficiency states
5. Molecular basis of alpha-1-antitrypsin deficiency
6. Complete sequence of the cDNA for human alpha 1-antitrypsin and the gene for the S variant
7. Alpha-1-antitrypsin genotypes and phenotypes
8. Alpha 1-antitrypsin null (isola di procida): An alpha 1-antitrypsin deficiency allele caused by deletion of all alpha 1-antitrypsin coding exons
9. Deletion/frameshift mutation in the alpha 1-antitrypsin null allele, PI*QObolton
10. Identification and DNA sequence analysis of 15 new alpha 1-antitrypsin variants, including two PI*QO alleles and one deficient PI*M allele
11. Characterization of the intracellular mechanism causing the alpha-1-antitrypsin Nullgranite falls deficiency state
12. A null deficiency allele of alpha 1-antitrypsin, QOludwigshafen, with altered tertiary structure
13. Alpha 1-antitrypsin gene mutation hot spot associated with the formation of a retained and degraded null variant
14. Alpha 1-antitrypsin nullGranite Falls, a nonexpressing alpha 1-antitrypsin gene associated with a frameshift to stop mutation in a coding exon
15. A frameshift mutation results in a truncated alpha 1-antitrypsin that is retained within the rough endoplasmic reticulum
16. An alpha-1-antitrypsin nonsense mutation associated with a retained truncated protein and reduced mRNA
17. Characterization of a human alpha1-antitrypsin null allele involving aberrant mRNA splicing
18. Human a1-proteinase inhibitor: Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function
19. Alpha 1-antitrypsin deficiency and emphysema caused by homozygous inheritance of non-expressing alpha 1-antitrypsin genes
20. Alpha-1-antitrypsin deficiency caused by the Alpha-1-antitrypsin Null mattawa gene
21. Stability and degradation of mRNA
22. Messenger RNA degradation in eukaryotes
23. Nonsense but not missense mutations can decrease the abundance of nuclear mRNA for the mouse major urinary protein, while both types of mutations can facilitate exon skipping
24. Translation to near the distal end of the penultimate exon is required for normal levels of spliced triosephosphate isomerase mRNA
25. Soluble aggregates of the human PiZ alpha 1-antitrypsin variant are degraded within the endoplasmic reticulum by a mechanism sensitive to inhibitors of protein synthesis
26. Intracellular degradation of the transport-impaired human PiZ alpha 1-antitrypsin variant. Biochemical mapping of the degradative event among compartments of the secretory pathway
27. Intracellular disposal of incompletely folded human alpha1-antitrypsin involves release from calnexin and post-translational trimming of asparagine-linked oligosaccharides